Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
Insiders
Income Statement
Balance Sheet
Cash Flow Statement
Segments
Common Size IS
Op Efficiency
Credit Analysis
Tarsus Pharmaceuticals, Inc.
Segments
Chart
Annual
|
Quarterly
|
TTM
In millions, except per share items
Dec-31-22
Dec-31-21
Dec-31-20
Dec-31-19
Dec-31-18
8-K
10-K
10-K
10-K
S-1/A
Revenues
License fees
23.9
Research and development
42.6
Mix
License fees
92.6%
Research and development
165.1%
Growth
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy